Wallace Akerley
About
In The Last Decade
Wallace Akerley
26 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 710
- Pulmonary and Respiratory Medicine 421
- Epidemiology 276
- Molecular Biology 254
- Genetics 96
Countries citing papers authored by Wallace Akerley
This map shows the geographic impact of Wallace Akerley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wallace Akerley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wallace Akerley more than expected).
Fields of papers citing papers by Wallace Akerley
This network shows the impact of papers produced by Wallace Akerley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wallace Akerley. The network helps show where Wallace Akerley may publish in the future.
Co-authorship network of co-authors of Wallace Akerley
This figure shows the co-authorship network connecting the top 25 collaborators of Wallace Akerley. A scholar is included among the top collaborators of Wallace Akerley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wallace Akerley. Wallace Akerley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 107 | |
| 5 | 23 | |
| 6 | 6 | |
| 7 | 2 | |
| 8 | Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer breakdown → | 397 |
| 9 | 26 | |
| 10 | 29 | |
| 11 | 129 | |
| 12 | 1 | |
| 13 | 8 | |
| 14 | 5 | |
| 15 | Paclitaxel, carboplatin and radiation therapy for non-small-cell lung cancer. | 7 |
| 16 | 102 | |
| 17 | Preliminary analysis of paclitaxel, carboplatin, and concurrent radiation in the treatment of patients with advanced non-small cell lung cancer | 2 |
| 18 | Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer. | 15 |
| 19 | 130 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.